Clinical Trial

VR-Based Optokinetic Stimulation in Multiple Sclerosis

Study acronym: VR-OKS-MS
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 9, 2025 (before its estimated October 2025 completion). Its status may not reflect the trial's current state.
Summary
The aim of this study is to investigate the acute effects of virtual reality-based optokinetic stimulation on postural sway and motion sickness symptoms in individuals with multiple sclerosis (MS)
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-08-25; most recent amendment 2025-09-08.
Trial Details
NCT Number NCT07150520
Lead Sponsor Avrasya University
Collaborators: Hacettepe University
Conditions Multiple Sclerosis
Enrollment 30 participants
Start Date 2025-09-15
Primary Completion 2025-10 (estimated)
Study Completion 2025-10 (estimated)
Updated on ClinicalTrials.gov 2025-09-09